We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+9.56%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.95B
AUM Growth
+$323M
Cap. Flow
+$326M
Cap. Flow %
8.24%
Top 10 Hldgs %
35.62%
Holding
121
New
38
Increased
29
Reduced
19
Closed
34

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$100M
2
MCK icon
McKesson
MCK
+$82.1M
3
SYK icon
Stryker
SYK
+$68M
4
PFE icon
Pfizer
PFE
+$67.6M
5
GILD icon
Gilead Sciences
GILD
+$63.5M

Sector Composition

Rank Sector Weight
1 Healthcare 47.61%
2 Technology 10.42%
3 Communication Services 8.14%
4 Industrials 7%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLAB icon
76
Silicon Laboratories
SLAB
$7.17B
$3.44M 0.09%
+63,709
New +$3.41M
THC icon
77
CALL
Tenet Healthcare
THC
$21B
$3.43M 0.09%
+965,900
New +$49.3M
MXL icon
78
MaxLinear
MXL
$5.88B
$2.33M 0.06%
+192,734
New +$1.94M
SIMO icon
79
Silicon Motion
SIMO
$8.29B
$2.32M 0.06%
+67,075
New +$2.19M
MSCC
80
DELISTED
Microsemi Corp
MSCC
$2.09M 0.05%
+59,711
New +$2.1M
SMTC icon
81
Semtech
SMTC
$11.3B
$1.91M 0.05%
+96,267
New +$2.24M
ISIL
82
DELISTED
Intersil Corp
ISIL
$1.65M 0.04%
+132,060
New +$1.8M
POWI icon
83
Power Integrations
POWI
$3.53B
$1.56M 0.04%
+69,026
New +$1.73M
SYK icon
84
CALL
Stryker
SYK
$129B
$545K 0.01%
+158,100
New +$15M
EXAR
85
DELISTED
Exar Corporation
EXAR
$531K 0.01%
+54,263
New +$567K
AAPL icon
86
CALL
Apple
AAPL
$4.95T
$303K 0.01%
+2,264,400
New +$72.4M
A icon
87
Agilent Technologies
A
$38.9B
-298,200
Closed -$12.4M
ACAD icon
88
Acadia Pharmaceuticals
ACAD
$4.35B
-249,855
Closed -$8.14M
AMT icon
89
American Tower
AMT
$77.7B
-480,730
Closed -$45.3M
AMZN icon
90
Amazon
AMZN
$2.49T
-389,940
Closed -$7.25M
ARMK icon
91
Aramark
ARMK
$15.2B
-1,045,039
Closed -$23.9M
BLK icon
92
Blackrock
BLK
$165B
-165,831
Closed -$60.7M
CCL icon
93
Carnival Corporation Ltd
CCL
$37.1B
-321,865
Closed -$15.4M
CF icon
94
CF Industries
CF
$18.4B
-897,020
Closed -$50.9M
DG icon
95
Dollar General
DG
$27.2B
-630,049
Closed -$47.5M
EXAS
96
DELISTED
Exact Sciences
EXAS
-1,331,742
Closed -$29.3M
GILD icon
97
CALL
Gilead Sciences
GILD
$162B
-740,800
Closed -$670K
GILD icon
98
Gilead Sciences
GILD
$162B
-647,337
Closed -$63.5M
HYG icon
99
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
-340,305
Closed -$30.8M
IART icon
100
Integra LifeSciences
IART
$1.52B
-295,257
Closed -$7.44M

Similar funds

PFM Health Sciences's Q2 2015 Portfolio in Review

As of Q2 2015, PFM Health Sciences held 121 positions worth $3.95B, up 8.9% from $3.63B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

PFM Health Sciences deployed $326M of net new capital in Q2 2015, opening 38 new positions and adding to 29 existing holdings. Its largest new stake was Aetna Inc: 779,930 shares worth $99.4M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 49% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Bausch Health, an estimated $100M trimmed.

  • PFM Health Sciences's largest Q2 2015 buy was Aetna Inc: 779,930 shares worth $99.4M.
  • PFM Health Sciences added most to HCA Healthcare in Q2 2015, an estimated $87.3M increase.
  • PFM Health Sciences's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $100M.
  • PFM Health Sciences fully exited McKesson in Q2 2015, selling an estimated $82.1M.
  • PFM Health Sciences's ten largest holdings make up 36% of its $3.95B portfolio in Q2 2015.
  • PFM Health Sciences opened 38 new positions and closed 34 in Q2 2015.
  • PFM Health Sciences's portfolio value rose 8.9% quarter-over-quarter to $3.95B.

Based on PFM Health Sciences's 13F filing for Q2 2015, filed 14 Aug 2015.